---
schema_version: "secwatch.filing_event.v1"
accession: "0001612630-25-000066"
form_type: "8-K"
ticker: "JYNT"
cik: "0001612630"
company_name: "JOINT Corp"
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-16T23:42:57.821446+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Joint Corp Q3 net income turns positive to $855K; sells 45 clinics for $4.5M; adds $12M buyback

## Summary
- Q3 revenue $13.4M (+6% YoY); consolidated net income $855K vs loss of $3.2M in Q3 2024.
- Adjusted EBITDA from continuing ops $1.4M vs $262K in Q3 2024; consolidated adjusted EBITDA $3.3M (+36%).
- Agreed to sell 45 Southern California clinics for $4.5M via asset purchase agreement (terms still being negotiated).
- Board authorized additional $12M for stock repurchase program; 540K shares bought for $5M since program start.
- Lowered FY2025 system-wide sales guidance to $530-534M and comp sales to (1)% to 0% from prior low-single-digit growth.

## SEC filing metadata
- accession: 0001612630-25-000066
- form_type: 8-K
- ticker: JYNT
- cik: 0001612630
- company_name: JOINT Corp
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1612630/000161263025000066/0001612630-25-000066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1612630/000161263025000066/jynt-20251102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001612630-25-000066
- JSON: https://secwatch.observer/filing/0001612630-25-000066.json
- Plain text: https://secwatch.observer/filing/0001612630-25-000066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.